Inhibition of HIV type 1 replication using lentiviral-mediated delivery of mutant tRNALys3A58U

AIDS Research and Human Retroviruses

Volumn 20, Issue 12, 2004, Pages 1324-1334

  Renda, Matthew J ^a   Bradel Tretheway, Birgit ^a   Planelles, Vicente ^b   Bambara, Robert A ^a   Dewhurst, Stephen ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LENTIVIRUS VECTOR; LYSINE; TRANSFER RNA;

ARTICLE; CELL CULTURE; DILUTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; MUTANT; PHENOTYPE; PRIORITY JOURNAL; VIRUS CULTURE; VIRUS INHIBITION; VIRUS ISOLATION; VIRUS REPLICATION; VIRUS RESISTANCE; WILD TYPE;

EID: 11244349360     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2004.20.1324     Document Type: Article

References (29)

1. Weiss R: Experimental biology and assay of RNA tumor viruses. In: RNA Tumor Viruses, 2nd Ed. Weiss R, Teich N, Varmus H, Coffin J, (eds.). Cold Spring Harbor Laboratories: Cold Spring Harbor, New York, 1982, pp. 209-260.
2. Levin HL: It's prime time for reverse transcriptase. Cell 1997;88:5-8.
3. Mak J, Jiang M, Wainberg MA, Hammarskjold ML, Rekosh D, and Kleiman L: Role of Pr160gag-pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J Virol 1994;68:2065-2072.
4. Gilboa E, Mitra SW, Goff S, and Baltimore D: A detailed model of reverse transcription and tests of crucial aspects. Cell 1979;18:93-100.
5. Zhang Z, Yu Q, Kang SM, Buescher J, and Morrow CD: Preferential completion of human immunodeficiency virus type 1 proviruses initiated with tRNASLys rather than tRNA1,2Lys. J Virol 1998;72:5464-5471.
6. Li Z, Shalom A, Huang Y, Mak J, Arts E, Wainberg MA, and Kleiman L: Multiple forms of tRNA(Lys3) in HIV-1. Biochem Biophys Res Commun 1996;227:530-540.
7. Kleiman L: tRNA(Lys3): The primer tRNA for reverse transcription in HIV-1. Int Union Biochem Mol Biol Life 2002;53:107-114.
8. Wu T, Guo J, Bess J, Henderson LE, and Levin JG: Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: Analysis in reconstituted and endogenous reverse transcription systems. J Virol 1999;73:4794-4805.
9. Marquet R (ed.). Importance of Modified Nucleolides in Replication of Retroviruses, Plant Pararetroviruses, and Retrotransposons, Vol. H. ASM Press, Washington, DC, 1998.
10. Renda MJ, Rosenblatt JD, Klimatcheva E, Demeter LM, Bambara RA, and Planelles V: Mutation of the methylated tRNA(Lys)(3) residue A58 disrupts reverse transcription and inhibits replication of human immunodeficiency virus type 1. J Virol 2001;75:9671-9678.
11. Follenzi A, Ailles LE, Bakovic S, Geuna M, and Naldini L: Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat Genet 2000;25:217-222.
12. White SM, Renda M, Nam NY, Klimatcheva E, Zhu Y, Fisk J, Halterman M, Rimel BJ, Federoff H, Pandya S, Rosenblatt JD, and Planelles V: Lentivirus vectors using human and simian immunodeficiency virus elements. J Virol 1999;73:2832-2840.
13. Planelles V, Haislip A, Withers-Ward ES, Stewart SA, Xie Y, Shah NP, and Chen ISY: A new reporter system for detection of retroviral infection. Gene Ther 1995;2:369-376.
14. Kim B, Hathaway TR, and Loeb LA: Human immunodeficiency virus reverse transcriptase. Functional mutants obtained by random mutagenesis coupled with genetic selection in Escherichia coli. J Biol Chem 1996;271:4872-4878.
15. Isel C, Marquet R, Keith G, Ehresmann C, and Ehresmann B: Modified nucleotides of tRNA(3Lys) modulate primer/template loop-loop interaction in the initiation complex of HIV-1 reverse transcription. J Biol Chem 1993;268:25269-25272.
16. Isel C, Ehresmann C, Keith G, Ehresmann B, and Marquet R: Initiation of reverse transcription of HIV-1: Secondary structure of the HIV-1 RNA/tRNA(3Lys) (template/primer). J Mol Biol 1995;247:236-250.
17. Wakefield JK, Wolf AG, and Morrow CD: Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys). J Virol 1995;69:6021-6029.
18. Beerens N, Groot F, and Berkhout B: Initiation of HIV-1 reverse transcription is regulated by a primer activation signal. J Biol Chem 2001;276:31247-31256.
19. Wakefield JK, Kang SM, and Morrow CD: Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His). J Virol 1996;70:966-975.
20. Kang SM, Zhang Z, and Morrow CD: Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNA(Met). J Virol 1997;71:207-217.
21. Cen S, Huang Y, Khorchid A, Darlix JL, Wainberg MA, and Kleiman L: The role of Pr55(gag) in the annealing of tRNA3Lys to human immunodeficiency virus type 1 genomic RNA. J Virol 1999;73:4485-4488.
22. Feng YX, Campbell S, Marvin D, Ehresmann B, Ehresmann C, and Rein A: The human immunodeficiency virus type 1 gag polyprotein has nucleic acid chaperone activity: Possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site. J Virol 1999;73:4251-4256.
23. Cen S, Khorchid A, Gabor J, Rong L, Wainberg MA, and Kleiman L: Roles of Pr55(gag) and NCp7 in tRNA(3)(Lys) genomic placement and the initiation step of reverse transcription in human immunodeficiency virus type 1. J Virol 2000;74:10796-10800.
24. Sarih-Cottin L, Bordier B, Musier-Forsyth K, Andreola ML, Barr PJ, and Litvak S: Preferential interaction of human immunodeficiency virus reverse transcriptase with two regions of primer tRNA(Lys) as evidenced by footprinting studies and inhibition with synthetic oligoribonucleotides. J Mol Biol 1992;226:1-6.
25. Auxilien S, Keith G, Le Grice SF, and Darlix JL: Role of post-transcriptional modifications of primer tRNALys,3 in the fidelity and efficacy of plus strand DNA transfer during HIV-1 reverse transcription. J Biol Chem 1999;274:4412-4420.
26. Wöhrl BM, Ehresmann B, Keith G, and Le Grice SF: Nuclease footprinting of human immunodeficiency virus reverse transcriptase/tRNA(Lys-3) complexes. J Biol Chem 1993;268:13617-13624.
27. Sissler M, Helm M, Frugier M, Giege R, and Florentz C: Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants. RNA 2004;10:841-853.
28. Guo F, Cen S, Niu M, Javanbakht H, and Kleiman L: Specific inhibition of the synthesis of human lysyl-tRNA synthetase results in decreases in tRNA(Lys) incorporation, tRNA(3)(Lys) annealing to viral RNA, and viral infectivity in human immunodeficiency virus type 1. J Virol 2003;77:9817-9822.
29. Chang Z, Westaway S, Li S, Zaia JA, Rossi JJ, and Scherer LJ: Enhanced expression and HIV-1 inhibition of chimeric tRNA(Lys3)-ribozymes under dual U6 snRNA and tRNA promoters. Mol Ther 2002;6:481-489.